1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anticoagulant Injections Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 LMWH 1.2.3 Unfractionated Heparin 1.2.4 Fibrinolytics 1.2.5 Other 1.3 Market by Application 1.3.1 Global Anticoagulant Injections Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 VTE 1.3.3 ACS/MI 1.3.4 AF 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anticoagulant Injections Market Perspective (2017-2028) 2.2 Anticoagulant Injections Growth Trends by Region 2.2.1 Anticoagulant Injections Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Anticoagulant Injections Historic Market Size by Region (2017-2022) 2.2.3 Anticoagulant Injections Forecasted Market Size by Region (2023-2028) 2.3 Anticoagulant Injections Market Dynamics 2.3.1 Anticoagulant Injections Industry Trends 2.3.2 Anticoagulant Injections Market Drivers 2.3.3 Anticoagulant Injections Market Challenges 2.3.4 Anticoagulant Injections Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anticoagulant Injections Players by Revenue 3.1.1 Global Top Anticoagulant Injections Players by Revenue (2017-2022) 3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2017-2022) 3.2 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Anticoagulant Injections Revenue 3.4 Global Anticoagulant Injections Market Concentration Ratio 3.4.1 Global Anticoagulant Injections Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Injections Revenue in 2021 3.5 Anticoagulant Injections Key Players Head office and Area Served 3.6 Key Players Anticoagulant Injections Product Solution and Service 3.7 Date of Enter into Anticoagulant Injections Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anticoagulant Injections Breakdown Data by Type 4.1 Global Anticoagulant Injections Historic Market Size by Type (2017-2022) 4.2 Global Anticoagulant Injections Forecasted Market Size by Type (2023-2028) 5 Anticoagulant Injections Breakdown Data by Application 5.1 Global Anticoagulant Injections Historic Market Size by Application (2017-2022) 5.2 Global Anticoagulant Injections Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Anticoagulant Injections Market Size (2017-2028) 6.2 North America Anticoagulant Injections Market Size by Country (2017-2022) 6.3 North America Anticoagulant Injections Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Anticoagulant Injections Market Size (2017-2028) 7.2 Europe Anticoagulant Injections Market Size by Country (2017-2022) 7.3 Europe Anticoagulant Injections Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Anticoagulant Injections Market Size (2017-2028) 8.2 Asia-Pacific Anticoagulant Injections Market Size by Country (2017-2022) 8.3 Asia-Pacific Anticoagulant Injections Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Anticoagulant Injections Market Size (2017-2028) 9.2 Latin America Anticoagulant Injections Market Size by Country (2017-2022) 9.3 Latin America Anticoagulant Injections Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anticoagulant Injections Market Size (2017-2028) 10.2 Middle East & Africa Anticoagulant Injections Market Size by Country (2017-2022) 10.3 Middle East & Africa Anticoagulant Injections Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Anticoagulant Injections Introduction 11.1.4 Sanofi Revenue in Anticoagulant Injections Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Genentech (Roche) 11.2.1 Genentech (Roche) Company Detail 11.2.2 Genentech (Roche) Business Overview 11.2.3 Genentech (Roche) Anticoagulant Injections Introduction 11.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022) 11.2.5 Genentech (Roche) Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Detail 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction 11.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Aspen 11.4.1 Aspen Company Detail 11.4.2 Aspen Business Overview 11.4.3 Aspen Anticoagulant Injections Introduction 11.4.4 Aspen Revenue in Anticoagulant Injections Business (2017-2022) 11.4.5 Aspen Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Detail 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Anticoagulant Injections Introduction 11.5.4 Pfizer Revenue in Anticoagulant Injections Business (2017-2022) 11.5.5 Pfizer Recent Development 11.6 Hepalink 11.6.1 Hepalink Company Detail 11.6.2 Hepalink Business Overview 11.6.3 Hepalink Anticoagulant Injections Introduction 11.6.4 Hepalink Revenue in Anticoagulant Injections Business (2017-2022) 11.6.5 Hepalink Recent Development 11.7 King-friend 11.7.1 King-friend Company Detail 11.7.2 King-friend Business Overview 11.7.3 King-friend Anticoagulant Injections Introduction 11.7.4 King-friend Revenue in Anticoagulant Injections Business (2017-2022) 11.7.5 King-friend Recent Development 11.8 CSBIO 11.8.1 CSBIO Company Detail 11.8.2 CSBIO Business Overview 11.8.3 CSBIO Anticoagulant Injections Introduction 11.8.4 CSBIO Revenue in Anticoagulant Injections Business (2017-2022) 11.8.5 CSBIO Recent Development 11.9 Amphastar Pharmaceuticals 11.9.1 Amphastar Pharmaceuticals Company Detail 11.9.2 Amphastar Pharmaceuticals Business Overview 11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction 11.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022) 11.9.5 Amphastar Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anticoagulant Injections Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of LMWH Table 3. Key Players of Unfractionated Heparin Table 4. Key Players of Fibrinolytics Table 5. Key Players of Other Table 6. Global Anticoagulant Injections Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Anticoagulant Injections Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Anticoagulant Injections Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Anticoagulant Injections Market Share by Region (2017-2022) Table 10. Global Anticoagulant Injections Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Anticoagulant Injections Market Share by Region (2023-2028) Table 12. Anticoagulant Injections Market Trends Table 13. Anticoagulant Injections Market Drivers Table 14. Anticoagulant Injections Market Challenges Table 15. Anticoagulant Injections Market Restraints Table 16. Global Anticoagulant Injections Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Anticoagulant Injections Market Share by Players (2017-2022) Table 18. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2021) Table 19. Ranking of Global Top Anticoagulant Injections Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Anticoagulant Injections Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Anticoagulant Injections Product Solution and Service Table 23. Date of Enter into Anticoagulant Injections Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Anticoagulant Injections Revenue Market Share by Type (2017-2022) Table 27. Global Anticoagulant Injections Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Anticoagulant Injections Revenue Market Share by Type (2023-2028) Table 29. Global Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Anticoagulant Injections Revenue Market Share by Application (2017-2022) Table 31. Global Anticoagulant Injections Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Anticoagulant Injections Revenue Market Share by Application (2023-2028) Table 33. North America Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Anticoagulant Injections Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Anticoagulant Injections Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million) Table 43. Sanofi Company Detail Table 44. Sanofi Business Overview Table 45. Sanofi Anticoagulant Injections Product Table 46. Sanofi Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 47. Sanofi Recent Development Table 48. Genentech (Roche) Company Detail Table 49. Genentech (Roche) Business Overview Table 50. Genentech (Roche) Anticoagulant Injections Product Table 51. Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 52. Genentech (Roche) Recent Development Table 53. Boehringer Ingelheim Company Detail Table 54. Boehringer Ingelheim Business Overview Table 55. Boehringer Ingelheim Anticoagulant Injections Product Table 56. Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 57. Boehringer Ingelheim Recent Development Table 58. Aspen Company Detail Table 59. Aspen Business Overview Table 60. Aspen Anticoagulant Injections Product Table 61. Aspen Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 62. Aspen Recent Development Table 63. Pfizer Company Detail Table 64. Pfizer Business Overview Table 65. Pfizer Anticoagulant Injections Product Table 66. Pfizer Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 67. Pfizer Recent Development Table 68. Hepalink Company Detail Table 69. Hepalink Business Overview Table 70. Hepalink Anticoagulant Injections Product Table 71. Hepalink Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 72. Hepalink Recent Development Table 73. King-friend Company Detail Table 74. King-friend Business Overview Table 75. King-friend Anticoagulant Injections Product Table 76. King-friend Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 77. King-friend Recent Development Table 78. CSBIO Company Detail Table 79. CSBIO Business Overview Table 80. CSBIO Anticoagulant Injections Product Table 81. CSBIO Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 82. CSBIO Recent Development Table 83. Amphastar Pharmaceuticals Company Detail Table 84. Amphastar Pharmaceuticals Business Overview Table 85. Amphastar Pharmaceuticals Anticoagulant Injections Product Table 86. Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Table 87. Amphastar Pharmaceuticals Recent Development Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global Anticoagulant Injections Market Share by Type: 2021 VS 2028 Figure 2. LMWH Features Figure 3. Unfractionated Heparin Features Figure 4. Fibrinolytics Features Figure 5. Other Features Figure 6. Global Anticoagulant Injections Market Share by Application in 2021 & 2028 Figure 7. VTE Case Studies Figure 8. ACS/MI Case Studies Figure 9. AF Case Studies Figure 10. Other Case Studies Figure 11. Anticoagulant Injections Report Years Considered Figure 12. Global Anticoagulant Injections Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Anticoagulant Injections Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Anticoagulant Injections Market Share by Region: 2021 VS 2028 Figure 15. Global Anticoagulant Injections Market Share by Players in 2021 Figure 16. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Anticoagulant Injections Revenue in 2021 Figure 18. North America Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Anticoagulant Injections Market Share by Country (2017-2028) Figure 20. United States Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Anticoagulant Injections Market Share by Country (2017-2028) Figure 24. Germany Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Anticoagulant Injections Market Share by Region (2017-2028) Figure 32. China Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Anticoagulant Injections Market Share by Country (2017-2028) Figure 40. Mexico Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Anticoagulant Injections Market Share by Country (2017-2028) Figure 44. Turkey Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Sanofi Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 47. Genentech (Roche) Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 48. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 49. Aspen Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 50. Pfizer Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 51. Hepalink Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 52. King-friend Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 53. CSBIO Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 54. Amphastar Pharmaceuticals Revenue Growth Rate in Anticoagulant Injections Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Sanofi Genentech (Roche) Boehringer Ingelheim Aspen Pfizer Hepalink King-friend CSBIO Amphastar Pharmaceuticals